Insights

Global Market Presence Vaxxinova operates in over 75 countries with facilities in 12 key markets, indicating a strong international footprint that offers numerous opportunities to expand sales through targeted regional marketing efforts and strategic partnerships.

Product Innovation Focus With a significant investment in R&D and a portfolio of innovative vaccines and diagnostic services for livestock and fish, the company is positioned to meet evolving industry needs, presenting potential for upselling advanced solutions to existing clients.

Acquisition Strategy Recent acquisitions, such as Labovet in Brazil, demonstrate Vaxxinova’s growth through mergers and acquisitions, creating sales opportunities by cross-selling products across newly expanded regional markets and strengthening local customer relationships.

Industry Event Participation Active participation in international events like Poultry Days and the International Production & Processing Expo enhances brand visibility among key industry decision-makers, offering direct access to potential clients and collaborations in animal health markets.

Leadership and Talent Growth Strategic hires in executive roles and regional representatives highlight a focus on strengthening leadership and local presence, which can be leveraged to develop customized client solutions and deepen engagement with tier-one industry players.

Vaxxinova Tech Stack

Vaxxinova uses 8 technology products and services including WordPress, MySQL, oEmbed, and more. Explore Vaxxinova's tech stack below.

  • WordPress
    Content Management System
  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Font Awesome
    Font Scripts
  • Claro
    Human Resource Management System
  • PHP
    Programming Languages
  • HSTS
    Security
  • Google Tag Manager
    Tag Management

Media & News

Vaxxinova's Email Address Formats

Vaxxinova uses at least 1 format(s):
Vaxxinova Email FormatsExamplePercentage
First.Last@vaxxinova.comJohn.Doe@vaxxinova.com
89%
First.MiddleLast@vaxxinova.comJohn.MichaelDoe@vaxxinova.com
5%
FirstMiddleLast@vaxxinova.comJohnMichaelDoe@vaxxinova.com
4%
Last.First@vaxxinova.comDoe.John@vaxxinova.com
2%

Frequently Asked Questions

Where is Vaxxinova's headquarters located?

Minus sign iconPlus sign icon
Vaxxinova's main headquarters is located at 5 Transistorweg Nijmegen, Gelderland Netherlands. The company has employees across 5 continents, including EuropeSouth AmericaAsia.

What is Vaxxinova's official website and social media links?

Minus sign iconPlus sign icon
Vaxxinova's official website is vaxxinova.com and has social profiles on LinkedIn.

What is Vaxxinova's SIC code NAICS code?

Minus sign iconPlus sign icon
Vaxxinova's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 54194 - Veterinary Services.

How many employees does Vaxxinova have currently?

Minus sign iconPlus sign icon
As of April 2026, Vaxxinova has approximately 220 employees across 5 continents, including EuropeSouth AmericaAsia. Key team members include Ceo: V. V. S.Chief Operating Officer: O. R.Chief Scientific Officer: K. M.. Explore Vaxxinova's employee directory with LeadIQ.

What industry does Vaxxinova belong to?

Minus sign iconPlus sign icon
Vaxxinova operates in the Veterinary Services industry.

What technology does Vaxxinova use?

Minus sign iconPlus sign icon
Vaxxinova's tech stack includes WordPressMySQLoEmbedFont AwesomeClaroPHPHSTSGoogle Tag Manager.

What is Vaxxinova's email format?

Minus sign iconPlus sign icon
Vaxxinova's email format typically follows the pattern of First.Last@vaxxinova.com. Find more Vaxxinova email formats with LeadIQ.

When was Vaxxinova founded?

Minus sign iconPlus sign icon
Vaxxinova was founded in 2010.

Vaxxinova

Veterinary ServicesGelderland, Netherlands201-500 Employees

Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases. We create high quality solutions to improve animal health and to support our customers. We believe that innovation and excellence in research are essential to produce premium products that match the current and future requirements in animal health. That is why Vaxxinova invests strongly in R&D. 

Locations
Our current network comprises production, research & development, sales and diagnostic facilities in 12 countries: Brazil, Chile, Croatia, Germany, Italy, Japan, Jordan, Norway, the Netherlands, South Africa, Thailand and the USA. Vaxxinova is active in more than 75 countries.

Job opportunities
We are currently expanding our organization, both locally and at the head office. We are looking for new talents and professionals who feel at home in a driven, entrepreneurial and down to earth working environment. Vaxxinova offers their employees excellent opportunities for further professional development.

Background
Vaxxinova is part of the family-owned EW Group, a German based company specialized in the field of Life Sciences: genetics, nutrition and animal health. The EW Group is highly committed to R&D, operates in more than 165 countries and records consistent international growth.

Section iconCompany Overview

Headquarters
5 Transistorweg Nijmegen, Gelderland Netherlands
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
54194 - Veterinary Services
Founded
2010
Employees
201-500

Section iconFunding & Financials

  • $1M$10M

    Vaxxinova's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Vaxxinova's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.